Home LiteratureArticle Details
PMID: 17897455 Published · epublish English Journal Article

pHUSH: a single vector system for conditional gene expression.

BMC biotechnology ·Vol. 7 ·2007-09-26 ·Pages 61

Gray DC, Hoeflich KP, Peng L, Gu Z, Gogineni A, Murray LJ, Eby M, Kljavin N, Seshagiri S, Cole MJ, Davis DP

Abstract

Conditional expression vectors have become a valuable research tool to avoid artefacts that may result from traditional gene expression studies. However, most systems require multiple plasmids that must be independently engineered into the target system, resulting in experimental delay and an increased potential for selection of a cell subpopulation that differs significantly from the parental line. We have therefore developed pHUSH, an inducible expression system that allows regulated expression of shRNA, miRNA or cDNA cassettes on a single viral vector. Both Pol II and Pol III promoters have been successfully combined with a second expression cassette containing a codon-optimized tetracycline repressor and selectable marker. We provide examples of how pHUSH has been successfully employed to study the function of target genes in a number of cell types within in vitro and in vivo assays, including conditional gene knockdown in a murine model of brain cancer. We have successfully developed and employed a single vector system that enables Doxycycline regulated RNAi or transgene expression in a variety of in vitro and in vivo model systems. These studies demonstrate the broad application potential of pHUSH for conditional genetic engineering in mammalian cells.

MeSH Terms
Gene Expression/genetics Gene Targeting/methods Genetic Vectors/genetics Protein Engineering/methods Recombinant Proteins/genetics Transfection/methods
Chemicals
Recombinant Proteins
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Gray Daniel C
Department of Molecular Biology, Genentech Inc, South San Francisco, California, USA. Daniel.Gray@ucsf.edu
Hoeflich Klaus P
Peng Li
Gu Zhenyu
Gogineni Alvin
Murray Lesley J
Eby Mike
Kljavin Noelyn
Seshagiri Somasekar
Cole Mary J
Davis David P
References (48)
48 references, click to expand
  1. A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma.
    J Immunol Methods. 1998 Oct 1;219(1-2):45-55 PMID: 9831387
  2. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells.
    Hum Gene Ther. 1998 Sep 1;9(13):1939-50 PMID: 9741432
  3. RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age.
    Oncogene. 2004 Nov 1;23(51):8401-9 PMID: 15517022
  4. Development of a tightly regulated U6 promoter for shRNA expression.
    FEBS Lett. 2004 Nov 19;577(3):376-80 PMID: 15556613
  5. Targeting the mitogen-activated protein kinase cascade to treat cancer.
    Nat Rev Cancer. 2004 Dec;4(12):937-47 PMID: 15573115
  6. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1.
    Oncogene. 2005 Apr 21;24(18):2973-80 PMID: 15735719
  7. Mammalian RNAi: a practical guide.
    Biotechniques. 2005 Aug;39(2):215-24 PMID: 16116795
  8. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells.
    Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13212-7 PMID: 16141338
  9. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.
    Nat Genet. 2005 Nov;37(11):1289-95 PMID: 16200064
  10. Second-generation shRNA libraries covering the mouse and human genomes.
    Nat Genet. 2005 Nov;37(11):1281-8 PMID: 16200065
  11. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers.
    Cancer Res. 2005 Nov 1;65(21):9751-61 PMID: 16266996
  12. Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.
    Cancer Res. 2006 Jan 15;66(2):999-1006 PMID: 16424035
  13. A versatile tool for conditional gene expression and knockdown.
    Nat Methods. 2006 Feb;3(2):109-16 PMID: 16432520
  14. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
    Neurosurgery. 2006 Feb;58(2):365-72; discussion 365-72 PMID: 16462491
  15. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.
    Cell. 2006 Mar 24;124(6):1283-98 PMID: 16564017
  16. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155.
    Nucleic Acids Res. 2006;34(7):e53 PMID: 16614444
  17. High-throughput RNAi screening in cultured cells: a user's guide.
    Nat Rev Genet. 2006 May;7(5):373-84 PMID: 16607398
  18. A loss-of-function RNA interference screen for molecular targets in cancer.
    Nature. 2006 May 4;441(7089):106-10 PMID: 16572121
  19. Death-receptor activation halts clathrin-dependent endocytosis.
    Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10283-8 PMID: 16801533
  20. Tuning silence: conditional systems for RNA interference.
    Nat Methods. 2006 Sep;3(9):682-8 PMID: 16929312
  21. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.
    Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13759-64 PMID: 16945906
  22. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
    Mol Ther. 2007 May;15(5):938-45 PMID: 17311008
  23. Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter.
    Hum Gene Ther. 2000 Mar 1;11(4):577-85 PMID: 10724036
  24. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
    Nature. 2001 May 24;411(6836):494-8 PMID: 11373684
  25. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.
    Science. 2001 Aug 3;293(5531):876-80 PMID: 11423618
  26. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.
    Genes Dev. 2002 Apr 15;16(8):948-58 PMID: 11959843
  27. A system for stable expression of short interfering RNAs in mammalian cells.
    Science. 2002 Apr 19;296(5567):550-3 PMID: 11910072
  28. DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis.
    Nucleic Acids Res. 2002 May 15;30(10):e43 PMID: 12000848
  29. Mutations of the BRAF gene in human cancer.
    Nature. 2002 Jun 27;417(6892):949-54 PMID: 12068308
  30. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells.
    Nucleic Acids Res. 2003 Jan 15;31(2):700-7 PMID: 12527779
  31. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.
    EMBO Rep. 2003 Jun;4(6):609-15 PMID: 12776180
  32. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
    Nature. 2003 Jul 10;424(6945):223-8 PMID: 12853964
  33. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.
    J Virol. 2003 Aug;77(16):8957-61 PMID: 12885912
  34. Establishment of conditional vectors for hairpin siRNA knockdowns.
    Nucleic Acids Res. 2003 Aug 1;31(15):e77 PMID: 12888529
  35. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro.
    Cancer Res. 2003 Aug 15;63(16):4801-4 PMID: 12941798
  36. New tools for functional mammalian cancer genetics.
    Nat Rev Cancer. 2003 Oct;3(10):781-9 PMID: 14570045
  37. Inducible shRNA expression for application in a prostate cancer mouse model.
    Nucleic Acids Res. 2003 Nov 1;31(21):e127 PMID: 14576327
  38. Enhancement of RNAi activity by improved siRNA duplexes.
    FEBS Lett. 2004 Jan 16;557(1-3):193-8 PMID: 14741366
  39. A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
    Nature. 2004 Mar 25;428(6981):431-7 PMID: 15042092
  40. CRE recombinase-inducible RNA interference mediated by lentiviral vectors.
    Proc Natl Acad Sci U S A. 2004 May 11;101(19):7347-51 PMID: 15123829
  41. miRNAs on the move: miRNA biogenesis and the RNAi machinery.
    Curr Opin Cell Biol. 2004 Jun;16(3):223-9 PMID: 15145345
  42. Cre-lox-regulated conditional RNA interference from transgenes.
    Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10380-5 PMID: 15240889
  43. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
    Nat Med. 2004 Aug;10(8):816-20 PMID: 15235598
  44. Adenovirus vector-mediated doxycycline-inducible RNA interference.
    Hum Gene Ther. 2004 Aug;15(8):813-9 PMID: 15319038
  45. Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA.
    Nucleic Acids Res. 1990 Feb 25;18(4):937-47 PMID: 1690394
  46. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2897-902 PMID: 8610139
  47. Visualizing gene expression in living mammals using a bioluminescent reporter.
    Photochem Photobiol. 1997 Oct;66(4):523-31 PMID: 9337626
  48. Essential role for oncogenic Ras in tumour maintenance.
    Nature. 1999 Jul 29;400(6743):468-72 PMID: 10440378
Article Info
Journal
BMC biotechnology
Abbr.
BMC Biotechnol
ISSN
1472-6750
Published
2007-09-26
Epub
2007-00-26
Pages
61
Language
English
Region
England
NLM ID
101088663
PMCID
PMC2174931
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com